Diabetes drug cuts prostate cancer risk
A University of Otago study involving 2.25 million type 2 diabetics suggests that the drug metformin is associated with a reduced risk of prostate cancer. Researchers believe these findings warrant further investigation into the drug's potential as a preventative measure for men.
Why it matters
Repurposing common, affordable drugs for cancer prevention could have massive public health implications and cost savings.
You are not permitted to download, save or email this image. Visit image gallery to purchase the image.
The article presents scientific findings based on a study without injecting opinion or bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in